DE59814423D1 - METHOD FOR PRODUCING HUMANEOUS BLOOD CYTOKINES - Google Patents
METHOD FOR PRODUCING HUMANEOUS BLOOD CYTOKINESInfo
- Publication number
- DE59814423D1 DE59814423D1 DE59814423T DE59814423T DE59814423D1 DE 59814423 D1 DE59814423 D1 DE 59814423D1 DE 59814423 T DE59814423 T DE 59814423T DE 59814423 T DE59814423 T DE 59814423T DE 59814423 D1 DE59814423 D1 DE 59814423D1
- Authority
- DE
- Germany
- Prior art keywords
- aliquot
- cells
- humaneous
- producing
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Abstract
A method for preparing autologous human blood cytokines comprises: (a) treating whole blood from a donor to separate a preparation comprising white blood cells, plasma and an antigen especially tumour cells from erythrocytes; (b) dividing the preparation into first and second aliquots; (c) demasking the cells in the first aliquot rendering the tumour cells recognisable as foreign by the donor's immune system; and (d) incubating the first aliquot with the second aliquot. Also claimed is a cytokine-containing product obtained by the above method.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19746865 | 1997-10-23 | ||
DE19821843A DE19821843A1 (en) | 1997-10-23 | 1998-05-15 | Preparation of autologous human blood cytokine(s) |
PCT/EP1998/006757 WO1999021887A2 (en) | 1997-10-23 | 1998-10-23 | Method for the production of human blood cytokines |
Publications (1)
Publication Number | Publication Date |
---|---|
DE59814423D1 true DE59814423D1 (en) | 2010-01-28 |
Family
ID=7846417
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19821843A Withdrawn DE19821843A1 (en) | 1997-10-23 | 1998-05-15 | Preparation of autologous human blood cytokine(s) |
DE59814423T Expired - Lifetime DE59814423D1 (en) | 1997-10-23 | 1998-10-23 | METHOD FOR PRODUCING HUMANEOUS BLOOD CYTOKINES |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19821843A Withdrawn DE19821843A1 (en) | 1997-10-23 | 1998-05-15 | Preparation of autologous human blood cytokine(s) |
Country Status (2)
Country | Link |
---|---|
AT (1) | ATE452144T1 (en) |
DE (2) | DE19821843A1 (en) |
-
1998
- 1998-05-15 DE DE19821843A patent/DE19821843A1/en not_active Withdrawn
- 1998-10-23 AT AT98955520T patent/ATE452144T1/en active
- 1998-10-23 DE DE59814423T patent/DE59814423D1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE19821843A1 (en) | 1999-04-29 |
ATE452144T1 (en) | 2010-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68923805D1 (en) | METHOD FOR PRODUCING OPTICALLY ACTIVE 1,3-BUTANEDIOL. | |
ATE153858T1 (en) | LIGAND FOR THE NEW GENE PRODUCT | |
ATE268353T1 (en) | METHOD FOR PRODUCING UHMWPE DOPED WITH ANTIOXIDANT AND IMPLANT PRODUCED THEREFROM | |
PT966447E (en) | SMALL UTILIZATION MOLECULES IN THE TREATMENT OF INFLAMMATORY DISEASES | |
ATE358493T1 (en) | HUMAN MESENCHYMAL STEM CELLS FROM PERIPHERAL BLOOD | |
ES2164633T3 (en) | SYNTHETIC VEGETABLE GENES AND PROCEDURE FOR PREPARATION. | |
ATE343396T1 (en) | IMMUNO-BOOSTING COMPOSITION IN SOLID ADMINISTRATION FORM WITH COLLAGEN OR POLYDIMETHYLSILOXANE AS CARRIERS | |
ATE250625T1 (en) | ESSENTIALLY PURE ZONULIN AS A PHYSIOLOGICAL MODULATOR OF ßTIGHT JUNCTIONSß IN MAMMALS | |
DE3766216D1 (en) | METHOD FOR PRODUCING LAMINATES. | |
FR2491334B1 (en) | ||
DE69001573D1 (en) | COMPOSITIONS FOR THE PRODUCTION OF D3 ACTIVE VITAMINS AND METHODS FOR THE PRODUCTION OF STABLE D3 ACTIVE VITAMINS USED THEREOF. | |
DE68908223D1 (en) | METHOD FOR THE PRODUCTION OF VERY PURE, DENSE, LARGE-PARTICLE SILICONE. | |
ATE190061T1 (en) | METHOD FOR PRODUCING ALKOXYSILANES | |
DE3783199D1 (en) | METHOD FOR PRODUCING 4,4 'DIAMINODIPHENYLMETHANE AND DERIVATIVES THEREOF. | |
DE59814423D1 (en) | METHOD FOR PRODUCING HUMANEOUS BLOOD CYTOKINES | |
DE69015945D1 (en) | Process for the preparation of p, p'-biphenol. | |
DE69013429D1 (en) | Process for the preparation of 2,2-dimethyl-3-hydroxypropyl-2,2-dimethyl-3-hydroxypropionate. | |
DE3860105D1 (en) | METHOD FOR PRODUCING 4,4'-DICHLORDIPHENYL SULPHONES. | |
DE3888887D1 (en) | Monoclonal antibodies against E7 protein of the human papilloma virus type 16, process for their preparation and their use. | |
NO965087L (en) | Isolated nucleic acid molecule encoding a tumor rejection antigen precursor, and use thereof | |
DE3781425D1 (en) | METHOD FOR PRODUCING ALPHA, BETA-UNSATURATED ALDEHYDES. | |
IT1198233B (en) | METHOD FOR THE DETERMINATION OF ANTI-SPORTS ANTIBODIES OF P. FALCIPARUM IN HUMAN BLOOD | |
DE3779247D1 (en) | METHOD FOR PRODUCING 2,3,5-TRIMETHYLHYDROQUINONE. | |
DE68917379D1 (en) | Process for the production of proteins similar to natural human apolipoprotein-E. | |
ES2061731T3 (en) | EXTRACTION PROCEDURE OF MEMBRANE ANTIGENS WITH IMMUNOGENIC PROPERTIES OF HUMAN NEOPLASTIC CELLS AND THE PRODUCTS SO OBTAINED. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |